Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease.

van Meurs JB, Pare G, Schwartz SM, Hazra A, Tanaka T, Vermeulen SH, Cotlarciuc I, Yuan X, Mälarstig A, Bandinelli S, Bis JC, Blom H, Brown MJ, Chen C, Chen YD, Clarke RJ, Dehghan A, Erdmann J, Ferrucci L, Hamsten A, Hofman A, Hunter DJ, Goel A, Johnson AD, Kathiresan S, Kampman E, Kiel DP, Kiemeney LA, Chambers JC, Kraft P, Lindemans J, McKnight B, Nelson CP, O'Donnell CJ, Psaty BM, Ridker PM, Rivadeneira F, Rose LM, Seedorf U, Siscovick DS, Schunkert H, Selhub J, Ueland PM, Vollenweider P, Waeber G, Waterworth DM, Watkins H, Witteman JC, den Heijer M, Jacques P, Uitterlinden AG, Kooner JS, Rader DJ, Reilly MP, Mooser V, Chasman DI, Samani NJ, Ahmadi KR.

Am J Clin Nutr. 2013 Sep;98(3):668-76. doi: 10.3945/ajcn.112.044545. Epub 2013 Jul 3.

2.

Influence of methionine synthase (A2756G) and methionine synthase reductase (A66G) polymorphisms on plasma homocysteine levels and relation to risk of coronary artery disease.

Laraqui A, Allami A, Carrié A, Coiffard AS, Benkouka F, Benjouad A, Bendriss A, Kadiri N, Bennouar N, Benomar A, Guedira A, Raisonnier A, Fellati S, Srairi JE, Benomar M.

Acta Cardiol. 2006 Feb;61(1):51-61.

PMID:
16485733
3.
4.

Effect of genetic variants associated with plasma homocysteine levels on stroke risk.

Cotlarciuc I, Malik R, Holliday EG, Ahmadi KR, Paré G, Psaty BM, Fornage M, Hasan N, Rinne PE, Ikram MA, Markus HS, Rosand J, Mitchell BD, Kittner SJ, Meschia JF, van Meurs JB, Uitterlinden AG, Worrall BB, Dichgans M, Sharma P; METASTROKE and the International Stroke Genetics Consortium.

Stroke. 2014 Jul;45(7):1920-4. doi: 10.1161/STROKEAHA.114.005208. Epub 2014 May 20.

5.

Hyperhomocysteinaemia, methylenetetrahydrofolate reductase polymorphism and risk of coronary artery disease.

Kerkeni M, Addad F, Chauffert M, Myara A, Gerhardt M, Chevenne D, Trivin F, Farhat MB, Miled A, Maaroufi K.

Ann Clin Biochem. 2006 May;43(Pt 3):200-6.

PMID:
16704755
6.

Association of the C677T MTHFR polymorphism with homocysteine, ox-LDL levels, and thiolactonase activities in the severity of coronary syndrome.

Koubaa N, Nakbi A, Hammami S, Mehri S, Attia N, Ben Farhat M, Hammami M.

Clin Appl Thromb Hemost. 2010 Oct;16(5):515-21. doi: 10.1177/1076029610369798. Epub 2010 Jun 7.

PMID:
20530057
7.

The association of plasma homocysteine, coronary risk factors and serum nitrite in patients with coronary artery disease, vascular syndrome x and healthy subjects.

Soysal D, Savaş S, Susam I, Cevik C, Göldeli E, Sözmen E, Güneri S.

Anadolu Kardiyol Derg. 2003 Mar;3(1):26-34, AXVIII-AXIX.

8.

Relation between plasma homocysteine, gene polymorphisms of homocysteine metabolism-related enzymes, and angiographically proven coronary artery disease.

Laraqui A, Allami A, Carrié A, Raisonnier A, Coiffard AS, Benkouka F, Bendriss A, Benjouad A, Bennouar N, El Kadiri N, Benomar A, Fellat S, Benomar M.

Eur J Intern Med. 2007 Oct;18(6):474-83. Epub 2007 Jul 12.

PMID:
17822659
9.

Association between endothelial nitric oxide gene intron 4a4b VNTR polymorphism and plasma homocysteine concentrations in Tunisian male patients with myocardial infarction.

Jemaa R, Kallel A, Sediri Y, Abdessalem S, Mourali MS, Feki M, Mechmeche R, Kaabachi N.

Nutr Res. 2012 May;32(5):342-6. doi: 10.1016/j.nutres.2012.03.013. Epub 2012 Apr 27.

PMID:
22652373
10.

Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms, plasma homocysteine, folate, and vitamin B12 levels and the extent of coronary artery disease.

Kölling K, Ndrepepa G, Koch W, Braun S, Mehilli J, Schömig A, Kastrati A.

Am J Cardiol. 2004 May 15;93(10):1201-6.

PMID:
15135689
11.

Polymorphisms in the CBS gene associated with decreased risk of coronary artery disease and increased responsiveness to total homocysteine lowering by folic acid.

Kruger WD, Evans AA, Wang L, Malinow MR, Duell PB, Anderson PH, Block PC, Hess DL, Graf EE, Upson B.

Mol Genet Metab. 2000 May;70(1):53-60.

PMID:
10833331
12.

Homocysteine concentration in coronary artery disease: Influence of three common single nucleotide polymorphisms.

Bickel C, Schnabel RB, Zengin E, Lubos E, Rupprecht H, Lackner K, Proust C, Tregouet D, Blankenberg S, Westermann D, Sinning C.

Nutr Metab Cardiovasc Dis. 2017 Feb;27(2):168-175. doi: 10.1016/j.numecd.2016.09.005. Epub 2016 Sep 17.

PMID:
27773468
13.

Cumulative effect of the plasma total homocysteine-related genetic variants on schizophrenia risk.

Kinoshita M, Numata S, Tajima A, Nishi A, Muraki S, Tsuchiya A, Umehara H, Watanabe SY, Imoto I, Ohmori T.

Psychiatry Res. 2016 Dec 30;246:833-837. doi: 10.1016/j.psychres.2016.10.017. Epub 2016 Oct 17.

PMID:
27810229
14.

Alcohol intake and methylenetetrahydrofolate reductase polymorphism modify the relation of folate intake to plasma homocysteine.

Chiuve SE, Giovannucci EL, Hankinson SE, Hunter DJ, Stampfer MJ, Willett WC, Rimm EB.

Am J Clin Nutr. 2005 Jul;82(1):155-62.

PMID:
16002814
15.

Genetic polymorphisms involved in folate metabolism and concentrations of methylmalonic acid and folate on plasma homocysteine and risk of coronary artery disease.

Biselli PM, Guerzoni AR, de Godoy MF, Eberlin MN, Haddad R, Carvalho VM, Vannucchi H, Pavarino-Bertelli EC, Goloni-Bertollo EM.

J Thromb Thrombolysis. 2010 Jan;29(1):32-40. doi: 10.1007/s11239-009-0321-7. Epub 2009 Mar 13.

PMID:
19283448
16.

Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: the A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal).

Freitas AI, Mendonça I, Guerra G, Brión M, Reis RP, Carracedo A, Brehm A.

Thromb Res. 2008;122(5):648-56. doi: 10.1016/j.thromres.2008.02.005. Epub 2008 Apr 1.

PMID:
18384842
17.

Homocysteine, traditional risk factors and impaired renal function in coronary artery disease.

Pizzolo F, Friso S, Olivieri O, Martinelli N, Bozzini C, Guarini P, Trabetti E, Faccini G, Corrocher R, Girelli D.

Eur J Clin Invest. 2006 Oct;36(10):698-704.

PMID:
16968465
18.

Relationship between lipid profiles and plasma total homocysteine, cysteine and the risk of coronary artery disease in coronary angiographic subjects.

Xiao Y, Zhang Y, Lv X, Su D, Li D, Xia M, Qiu J, Ling W, Ma J.

Lipids Health Dis. 2011 Aug 12;10:137. doi: 10.1186/1476-511X-10-137.

19.

Methylenetetrahydrofolate reductase polymorphisms and homocysteine-lowering effect of vitamin therapy in Singaporean stroke patients.

Ho GY, Eikelboom JW, Hankey GJ, Wong CR, Tan SL, Chan JB, Chen CP.

Stroke. 2006 Feb;37(2):456-60. Epub 2006 Jan 5.

PMID:
16397167
20.

Genome-wide association study of homocysteine in African Americans from the Jackson Heart Study, the Multi-Ethnic Study of Atherosclerosis, and the Coronary Artery Risk in Young Adults study.

Raffield LM, Ellis J, Olson NC, Duan Q, Li J, Durda P, Pankratz N, Keating BJ, Wassel CL, Cushman M, Wilson JG, Gross MD, Tracy RP, Rich SS, Reiner AP, Li Y, Willis MS, Lange EM, Lange LA.

J Hum Genet. 2018 Mar;63(3):327-337. doi: 10.1038/s10038-017-0384-9. Epub 2018 Jan 10.

Supplemental Content

Support Center